High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)

Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes

(2011) Hye Yoo et al.   Cardiovascular Diabetology

Azelnidipine and Amlodipine Anti-Coronary Atherosclerosis Trial in Hypertensive Patients Undergoing Coronary Intervention by Serial Volumetric Intravascular Ultrasound Analysis in Juntendo University (ALPS-J)

(2011) Takahiko Kojima et al.   CIRCULATION JOURNAL

Diabetes Adversely Affects Macrophages During Atherosclerotic Plaque Regression in Mice

(2011) S. Parathath et al.   DIABETES

High-Normal HbA1c Is a Strong Predictor of Type 2 Diabetes in the General Population

(2011) E. Bonora et al.   DIABETES CARE

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

(2011) P. Anagnostis et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Diabetes Mellitus Is a Major Negative Determinant of Coronary Plaque Regression During Statin Therapy in Patients With Acute Coronary Syndrome

(2010) Takafumi Hiro et al.   CIRCULATION JOURNAL

Glycaemic status influences the nature and severity of coronary artery disease

(2010) C. Berry et al.   DIABETOLOGIA

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

(2010) K. Eeg-Olofsson et al.   JOURNAL OF INTERNAL MEDICINE

Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol

(2010) Ozgur Bayturan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes

(2009) Alfonso Bellia et al.   ATHEROSCLEROSIS

Effect of Rosuvastatin on Coronary Atheroma in Stable Coronary Artery Disease

(2009) Tadateru Takayama et al.   CIRCULATION JOURNAL

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose

(2009) M. S. Kostapanos et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Low Levels of Low-Density Lipoprotein Cholesterol and Blood Pressure and Progression of Coronary Atherosclerosis

(2009) Adnan K. Chhatriwalla et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome

(2009) Takafumi Hiro et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Advanced glycation end products and C-peptide—modulators in diabetic vasculopathy and atherogenesis

(2009) Daniel Walcher et al.   Seminars in Immunopathology

The Role of AGEs in Cardiovascular Disease

(2008) Karin Jandeleit-Dahm et al.   CURRENT PHARMACEUTICAL DESIGN

Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 Diabetes: A Serial Intravascular Ultrasound Analysis

(2008) P. Jimenez-Quevedo et al.   DIABETES

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

(2008) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling

(2008) Stephen J. Nicholls et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY